je.st
news
Knight Therapeutics reacquires leishmaniasis drug Impavido
2016-03-16 02:20:59| Agriculture - Topix.net
Jonathan Ross Goodman is president and CEO and Jeffrey Kadanoff is CFO of Knight Therapeutics. The Montreal drug distributor has bought back the distribution rights to Impavido, a treatment for the rare parasitic disease leishmaniasis.
Tags: drug
knight
therapeutics
reacquires
Category:Agriculture and Forestry